US biotech firm Agensys has filed suit in California, accusing Suzhou Zelgen, Shanghai Zelgen, Gensun Biopharma, and Sheng of misappropriating its proprietary LRRC15 antibody technology to support a series of patent applications.
In A.L.M. v. Zydex, the Federal Circuit reversed a dismissal for lack of standing and held that patent owners retaining enforcement and royalty rights have Article III standing.
In Magnolia Medical v. Kurin, USPTO Director John Squires denied IPR institution and used the decision to lay out the factors he will weigh in future discretionary denial calls.
The Federal Circuit affirmed the Trademark Trial and Appeal Board's dismissal of Fuente Marketing's opposition to a stick-figure design mark for vaporizers, holding that the dissimilarity of the marks alone was dispositive on the question of likelihood of confusion.
